Aarti Pharmalabs Limited (AARTIPHARM.BO)
INR 642.25
(-1.17%)
INR 642.25
(-1.17%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.9 Billion INR | 12.1% |
| 2022 | 3.44 Billion INR | 447460.22% |
| 2021 | 2.09 Billion INR | -1574.85% |
| 2020 | 40.00 INR | 0.0% |
| 2019 | - INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 981.56 Million INR | -0.53% |
| 2024 Q1 | 964.6 Million INR | -17.46% |
| 2023 Q3 | 970.7 Million INR | 9.1% |
| 2023 FY | - INR | 12.1% |
| 2023 Q4 | 1.17 Billion INR | 21.07% |
| 2023 Q2 | 889.7 Million INR | 4.24% |
| 2023 Q1 | 853.5 Million INR | 4.6% |
| 2022 Q3 | 856.51 Million INR | 2.3% |
| 2022 FY | - INR | 447460.22% |
| 2022 Q2 | 837.29 Million INR | 2.61% |
| 2022 Q1 | 815.98 Million INR | -12.21% |
| 2022 Q4 | 815.98 Million INR | -4.73% |
| 2021 Q2 | -455.00 INR | 0.0% |
| 2021 Q1 | -455.00 INR | 0.0% |
| 2021 Q4 | 929.49 Million INR | -10.18% |
| 2021 Q3 | 1.03 Billion INR | 227430323.74% |
| 2021 FY | - INR | -1574.85% |
| 2020 FY | - INR | 0.0% |
| 2019 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | 59.348% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 93.673% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | 43.035% |
| Granules India Limited | 8.6 Billion INR | 54.562% |
| Indoco Remedies Limited | 2.64 Billion INR | -47.689% |
| Achyut Healthcare Limited | 524 Thousand INR | -745972.328% |
| Ajanta Pharma Limited | 12.56 Billion INR | 68.887% |
| Alkem Laboratories Limited | 24.19 Billion INR | 83.842% |
| Alpa Laboratories Limited | 86.12 Million INR | -4439.133% |
| Brooks Laboratories Limited | 41.72 Million INR | -9268.815% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | -65.878% |
| Bajaj HealthCare Limited | 444.51 Million INR | -779.478% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | -164.323% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 95.571% |
| Eris Lifesciences Limited | 6.98 Billion INR | 44.043% |
| FDC Limited | 4.4 Billion INR | 11.184% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | 65.537% |
| Gufic Biosciences Limited | 1.48 Billion INR | -164.063% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | 43.025% |
| Ipca Laboratories Limited | 13.29 Billion INR | 70.605% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -1108.625% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 4825.687% |
| Lasa Supergenerics Limited | -65.08 Million INR | 6107.097% |
| Laurus Labs Limited | 8 Billion INR | 51.169% |
| Lupin Limited | 36.96 Billion INR | 89.425% |
| Mankind Pharma Limited | 28.09 Billion INR | 86.085% |
| Medicamen Biotech Limited | 245.66 Million INR | -1491.394% |
| Medico Remedies Limited | 150.37 Million INR | -2499.728% |
| Megasoft Limited | 284.73 Million INR | -1273.022% |
| NATCO Pharma Limited | 18.79 Billion INR | 79.2% |
| Piramal Pharma Limited | 13.05 Billion INR | 70.055% |
| RPG Life Sciences Limited | 1.28 Billion INR | -205.066% |
| Sigachi Industries Limited | 883.39 Million INR | -342.543% |
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 97.175% |
| Suven Pharmaceuticals Limited | 4.67 Billion INR | 16.415% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -808.584% |
| Unichem Laboratories Limited | 742.35 Million INR | -426.623% |
| Wanbury Limited | 985.49 Million INR | -296.698% |
| Windlas Biotech Limited | 781.72 Million INR | -400.105% |
| ZIM Laboratories Limited | 462.09 Million INR | -746.017% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 93.046% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 204.775% |
| Divi's Laboratories Limited | 25.43 Billion INR | 84.627% |
| Hester Biosciences Limited | 539.47 Million INR | -624.678% |
| Procter & Gamble Health Limited | 3.01 Billion INR | -29.691% |
| Amrutanjan Health Care Limited | 682.53 Million INR | -472.777% |
| Bal Pharma Limited | 345.59 Million INR | -1031.224% |
| Strides Pharma Science Limited | 3.76 Billion INR | -3.845% |
| Venus Remedies Limited | 711.8 Million INR | -449.229% |
| Nectar Lifesciences Limited | 1.56 Billion INR | -149.996% |
| Shilpa Medicare Limited | 2.58 Billion INR | -51.06% |
| Aarti Drugs Limited | 3.24 Billion INR | -20.341% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | -49.982% |
| Suven Life Sciences Limited | -992.78 Million INR | 493.785% |
| Ind-Swift Limited | 1.06 Billion INR | -267.059% |
| Valiant Laboratories Limited | 12.73 Million INR | -30588.586% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | 58.12% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 238.539% |
| Themis Medicare Limited | 562.6 Million INR | -594.876% |
| Hikal Limited | 2.69 Billion INR | -45.211% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 88.833% |
| Sequent Scientific Limited | 549.8 Million INR | -611.062% |
| Novartis India Limited | 1.26 Billion INR | -207.998% |
| Wockhardt Limited | 1.08 Billion INR | -261.983% |
| Jubilant Pharmova Limited | 8 Billion INR | 51.169% |
| Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | -29829.712% |
| Neuland Laboratories Limited | 4.74 Billion INR | 17.665% |
| Morepen Laboratories Limited | 1.72 Billion INR | -126.508% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -1260.153% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -2134.643% |